Søren Mouritsen
Nessuna posizione attualmente
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Rodrigo Vazquez-Lombardi | M | - |
Engimmune Therapeutics AG
 Engimmune Therapeutics AG Packaged SoftwareTechnology Services Engimmune Therapeutics AG is a developer of off-the-shelf soluble T-cell receptor drugs to treat solid tumors. The company is based in Allschwil, Switzerland. The Swiss company's proprietary platform technologies enable them to engineer stable, multi-specific TCRs that have high affinity for target cancer antigens and trigger a potent and durable anti-cancer T-cell response without causing damage to healthy cells. The company was founded in 2021 as a spin-off of ETH Zurich from technologies developed by Dr. Rodrigo Vazquez-Lombardi and Professor Sai Reddy. Lars Nieba has been the CEO of the company since 2023. | 3 anni |
| Bent K. Jakobsen | M | - |
Engimmune Therapeutics AG
Engimmune Therapeutics AG Packaged SoftwareTechnology Services Engimmune Therapeutics AG is a developer of off-the-shelf soluble T-cell receptor drugs to treat solid tumors. The company is based in Allschwil, Switzerland. The Swiss company's proprietary platform technologies enable them to engineer stable, multi-specific TCRs that have high affinity for target cancer antigens and trigger a potent and durable anti-cancer T-cell response without causing damage to healthy cells. The company was founded in 2021 as a spin-off of ETH Zurich from technologies developed by Dr. Rodrigo Vazquez-Lombardi and Professor Sai Reddy. Lars Nieba has been the CEO of the company since 2023. | 2 anni |
| Lars Nieba | M | 56 |
Engimmune Therapeutics AG
Engimmune Therapeutics AG Packaged SoftwareTechnology Services Engimmune Therapeutics AG is a developer of off-the-shelf soluble T-cell receptor drugs to treat solid tumors. The company is based in Allschwil, Switzerland. The Swiss company's proprietary platform technologies enable them to engineer stable, multi-specific TCRs that have high affinity for target cancer antigens and trigger a potent and durable anti-cancer T-cell response without causing damage to healthy cells. The company was founded in 2021 as a spin-off of ETH Zurich from technologies developed by Dr. Rodrigo Vazquez-Lombardi and Professor Sai Reddy. Lars Nieba has been the CEO of the company since 2023. | 1 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Nikolai Søren Kirkby | M | - |
University of Copenhagen
| 4 anni |
| Jesper Nerlov | M | 56 |
University of Copenhagen
| 8 anni |
| Anders Hove | M | 58 |
University of Copenhagen
| 6 anni |
| Christian Meyersahm | M | - |
University of Copenhagen
| 4 anni |
| Soren Mogelsvang | M | 52 |
University of Copenhagen
| 4 anni |
| Liselotte Hyveled | F | 58 |
University of Copenhagen
| 1 anni |
| Jacob Rosenberg | M | 59 |
University of Copenhagen
| 3 anni |
| Hanne Andersen | F | - |
University of Copenhagen
| 4 anni |
| Jette Nygaard-Andersen | F | 55 |
University of Copenhagen
| 2 anni |
| Christian Lundgren | M | 58 |
University of Copenhagen
| 3 anni |
| Flemming Wagner | M | - |
University of Copenhagen
| 7 anni |
| Nicolas Nemery | M | - |
University of Copenhagen
| 4 anni |
| Jacob Vinther | M | 58 |
University of Copenhagen
| 4 anni |
| Guggi Heine Remme Kofod | M | - |
University of Copenhagen
| 6 anni |
| Jesper Alling Coverdale Kofoed | M | - |
University of Copenhagen
| 3 anni |
| Tomasz Piec | M | - |
University of Copenhagen
| 4 anni |
| Lars Jørn Hvidtfeldt Nielsen | M | 57 |
University of Copenhagen
| 1 anni |
| Birgitte Nauntofte | M | 66 |
University of Copenhagen
| 3 anni |
| Inger Ørum Kirk | F | 59 |
University of Copenhagen
| 3 anni |
| Elise Hauge | F | 57 |
University of Copenhagen
| 1 anni |
| Lars Løkke Rasmussen | M | 60 |
University of Copenhagen
| 3 anni |
| Nils Thomas Weincke | M | 61 |
University of Copenhagen
| 4 anni |
| Malene Lei Raben | F | - |
University of Copenhagen
| 3 anni |
| Adam Erritzøe | M | - |
University of Copenhagen
| 5 anni |
| Mads Hørberg | M | - |
University of Copenhagen
| 1 anni |
| Amanda Tonsgaard | F | - |
University of Copenhagen
| 5 anni |
| Jesper Gromada | M | - |
University of Copenhagen
| 3 anni |
| Peter Wulff | M | - |
University of Copenhagen
| 1 anni |
| Christian Grane | M | - |
University of Copenhagen
| 4 anni |
| Sai Reddy | M | - |
Engimmune Therapeutics AG
Engimmune Therapeutics AG Packaged SoftwareTechnology Services Engimmune Therapeutics AG is a developer of off-the-shelf soluble T-cell receptor drugs to treat solid tumors. The company is based in Allschwil, Switzerland. The Swiss company's proprietary platform technologies enable them to engineer stable, multi-specific TCRs that have high affinity for target cancer antigens and trigger a potent and durable anti-cancer T-cell response without causing damage to healthy cells. The company was founded in 2021 as a spin-off of ETH Zurich from technologies developed by Dr. Rodrigo Vazquez-Lombardi and Professor Sai Reddy. Lars Nieba has been the CEO of the company since 2023. | - |
| Jens Munch Holst | M | 60 |
University of Copenhagen
| 1 anni |
| Troels Albrechtsen | M | - |
University of Copenhagen
| 1 anni |
| Kresten Buch | M | - |
University of Copenhagen
| 5 anni |
| Lars Friis Mikkelsen | M | 56 |
University of Copenhagen
| 3 anni |
| Anja E. H. Holm | M | 59 |
University of Copenhagen
| 3 anni |
| Lars Lunde | M | 51 |
University of Copenhagen
| 6 anni |
| Morten Weicher Weicher | M | - |
University of Copenhagen
| - |
| Jakob Poulsen | M | - |
University of Copenhagen
| 6 anni |
| Torsten Lodberg Smed | M | 54 |
University of Copenhagen
| 5 anni |
| Arne Gerlyng-Hansen | M | 68 |
University of Copenhagen
| 7 anni |
| Amar A. Sethi | M | - |
University of Copenhagen
| 3 anni |
| Jakob Riis | M | 58 |
University of Copenhagen
| 1 anni |
| Karen Elisabeth Heltoft | F | - |
University of Copenhagen
| 4 anni |
| Niels Kærgård | M | 81 |
University of Copenhagen
| 3 anni |
| Niels Tækker Foged | M | 63 |
University of Copenhagen
| 3 anni |
| Heidi Schütt Larsen | F | - |
University of Copenhagen
| 1 anni |
| Carl Bek-Nielsen | M | 51 |
University of Copenhagen
| 4 anni |
| Jörgen Axel Thorball | M | 62 |
University of Copenhagen
| 3 anni |
| Jesper Theill Eriksen | M | 56 |
University of Copenhagen
| 3 anni |
| Thea Wulff Olesen | F | 58 |
University of Copenhagen
| 3 anni |
| Ole Sibbesen | M | - |
University of Copenhagen
| 3 anni |
| David Leeds | M | 55 |
University of Copenhagen
| 4 anni |
| Kim Lennart Dueholm | M | 61 |
University of Copenhagen
| 3 anni |
| Thomas Tscherning | M | - |
University of Copenhagen
| 3 anni |
| Mads Krogsgaard Thomsen | M | 63 |
University of Copenhagen
| 8 anni |
| Jens Due Olsen | M | 60 |
University of Copenhagen
| 1 anni |
| Michael Rasmussen | M | 59 |
University of Copenhagen
| 1 anni |
| Robert B. Madsen | M | - |
University of Copenhagen
| 4 anni |
| Birgitte Rønnow | M | - |
University of Copenhagen
| 3 anni |
| Tune Marschall | M | - |
University of Copenhagen
| 1 anni |
| Henrik Rasmussen | M | 65 |
University of Copenhagen
| 3 anni |
| Lykke Friis | M | 54 |
University of Copenhagen
| 6 anni |
| Anders Stahlschmidt | M | 57 |
University of Copenhagen
| 3 anni |
| Finn Sture Madsen | M | 57 |
University of Copenhagen
| 4 anni |
| Jens Fricke | M | 59 |
University of Copenhagen
| 1 anni |
| Kim Vilbour Andersen | M | - |
University of Copenhagen
| 3 anni |
| Zhan Li | M | 62 |
University of Copenhagen
| 2 anni |
| Dirk Schmelzer | M | 57 |
University of Copenhagen
| 4 anni |
| Hans Henrik Chrois Christensen | M | 59 |
University of Copenhagen
| 3 anni |
| Henrik N. Rasmussen | M | - |
University of Copenhagen
| 3 anni |
| Henriette Nielsen | F | 58 |
University of Copenhagen
| 4 anni |
| Bjørn Slot Jensen | M | - |
University of Copenhagen
| 4 anni |
| Peter Lindberg | M | - |
University of Copenhagen
| 4 anni |
| Dorte Westh Lehrmann | F | - |
University of Copenhagen
| 4 anni |
| Asbjørn Christoffersen | M | - |
University of Copenhagen
| 7 anni |
| Lone Lindsby | M | - |
University of Copenhagen
| 4 anni |
| Manuel Lopez-Figueroa | M | - |
University of Copenhagen
| 5 anni |
| Anne-Mette de Place Filippini | F | - |
University of Copenhagen
| 1 anni |
| Philip Christiani | M | - |
University of Copenhagen
| 6 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Danimarca | 78 | 95.12% |
| Svizzera | 4 | 4.88% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Søren Mouritsen
- Contatti personali
